pk101
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Sep 30, 2018 (NCT03553316)
Timeline
Indications
Mechanism of action
- Leukocyte elastaseINHIBITOR
ELANE inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04858659 | Phase 3 | May 20, 2021 | PMG Pharm Co., Ltd |
| NCT03876210 | Phase 1 | Jun 30, 2019 | PMG Pharm Co., Ltd |
| NCT03553316 | Phase 1 | Sep 30, 2018 | PMG Pharm Co., Ltd |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PMG Pharm Co., Ltd | For profit | 3 | 3 | 2 | 2018 |
1 organizations
Page 1 / 1